| Attacking Parkinson’s Via Gaucher Link, LTI Ready for Its Series A | Alex Lash | 01/15/15 | Boston |
| East Coast Biotech Roundup: LTI, SolveBio, Proteon, & More | Ben Fidler | 05/16/14 | Boston |
| LTI Corrals $5M to Exploit Link Between Gaucher, Parkinson’s | Alex Lash | 05/12/14 | Boston |
| What Biotech Pros Will Be Chirping About at JP Morgan This Week | Luke Timmerman | 01/13/14 | National |
| Moderna Vacuums Up Another $110M to Make Messenger RNA Drugs | Luke Timmerman | 11/20/13 | Boston |
| Xconomy Boston’s Top 20 Stories of Q2 2013: Editor’s Picks | Gregory T. Huang | 07/01/13 | Boston |
| East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More | Ben Fidler | 05/17/13 | Boston |
| Henri Termeer on Startups, Drug Prices, Getting Older (Part 2) | Luke Timmerman | 05/14/13 | National |
| Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) | Luke Timmerman | 05/13/13 | National |
| NanoString Pockets $15.3M For Diagnostic Rollout | Luke Timmerman | 12/04/12 | Seattle |
| U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts | Luke Timmerman | 08/06/12 | National |
| NanoString Nails Breast Cancer Study, Challenging Genomic Health | Luke Timmerman | 12/08/11 | Seattle |
| Best Buy Picks Up MindShift, Termeer Funds NanoString, Basho Adds $5M More, & More Boston-Area Deals News | Erin Kutz | 11/09/11 | Boston |
| NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics | Luke Timmerman | 11/07/11 | Seattle |
| Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News | Erin Kutz | 09/16/11 | Boston |
| PerkinElmer Acquires Caliper for $600M, VideoIQ Nabs $7.5M, MC10 Snags $2.5M, & More Boston-Area Deals News | Erin Kutz | 09/14/11 | Boston |
| Former Genzyme Boss Henri Termeer Gives $10M to MGH for Personalized Medicine | Luke Timmerman | 09/13/11 | Boston |
| Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News | Erin Kutz | 06/24/11 | Boston |
| Aveo Adds Termeer to Board, Monsanto Partners With Atlas, Biogen Drug Meets Clinical Goal, & More Boston-Area Life Sciences News | Erin Kutz | 04/15/11 | Boston |
| Genzyme’s Termeer Joins Aveo Board | Ryan McBride | 04/12/11 | Boston |
| Epizyme Nabs Eisai Deal, Termeer Could Make $221.2M From Genzyme Buyout, Gates Funds Nimbus, & More Boston-Area Life Sciences News | Erin Kutz | 03/11/11 | Boston |
| Kahoots Bought By RentJuice, Skyhook Enlists Sony, MassChallenge Adds $1M from MA, & More Boston-Area Deals News | Erin Kutz | 03/09/11 | Boston |
| Report: Genzyme Chief Could Reap $221.2M in Sanofi Deal | Ryan McBride | 03/08/11 | Boston |
| Genzyme, After Months of Holding Out, Agrees to be Sold to Sanofi-Aventis for $20.1B | Ryan McBride | 02/16/11 | Boston |
| Genzyme-Sanofi Deal Might Be Close, Report Says | Ryan McBride | 02/01/11 | Boston |
| Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010 | Gregory T. Huang | 12/27/10 | Boston |
| Genzyme to Let Diagnostics Unit Loose for $265M | Ryan McBride | 11/18/10 | Boston |
| Investors Suing Genzyme Over Its Handling of Sanofi’s $18.5B Buyout Bid | Ryan McBride | 10/13/10 | Boston |
| Sanofi-Aventis Launches Hostile Takeover Bid For Genzyme | Ryan McBride | 10/04/10 | Boston |
| Xconomy Boston’s Top 20 Stories of the Third Quarter: From A123 Expansion to Zynga Acquisition | Gregory T. Huang | 10/01/10 | Boston |
